Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms

  • Joanna Balding
    Thrombosis and Haemostasis Laboratory, Institute of Molecular Medicine, Trinity Centre for Health Sciences, St James’s Hospital, Dublin 8, Ireland
  • Wendy J. Livingstone
    Thrombosis and Haemostasis Laboratory, Institute of Molecular Medicine, Trinity Centre for Health Sciences, St James’s Hospital, Dublin 8, Ireland
  • Judith Conroy
    Department of Genetics, Trinity College, Dublin 2, Ireland
  • Lesley Mynett-Johnson
    Department of Genetics, Trinity College, Dublin 2, Ireland
  • Donald G. Weir
    Department of Clinical Medicine, Trinity Centre for Health Sciences, St James’s Hospital, Dublin 8, Ireland
  • Nasir Mahmud
    Department of Clinical Medicine, Trinity Centre for Health Sciences, St James’s Hospital, Dublin 8, Ireland
  • Owen P. Smith
    Department of Haematology, Our Lady’s Hospital for Sick Children, Crumlin, Dublin 12, Ireland

Abstract

<jats:p>THE mechanisms responsible for development of inflammatory bowel disease (IBD) have not been fully elucidated, although the main cause of disease pathology is attributed to up-regulated inflammatory processes. The aim of this study was to investigate frequencies of polymorphisms in genes encoding pro-inflammatory and anti-inflammatory markers in IBD patients and controls. We determined genotypes of patients with IBD (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" alttext="$n = 172$" id="E1"><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>172</mml:mn></mml:math>) and healthy controls (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" alttext="$n = 389$" id="E2"><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>389</mml:mn></mml:math>) for polymorphisms in genes encoding various cytokines (interleukin (IL)-1β, IL-6, tumour necrosis factor (TNF), IL-10, IL-1 receptor antagonist). Association of these genotypes to disease incidence and pathophysiology was investigated. No strong association was found with occurrence of IBD. Variation was observed between the ulcerative colitis study group and the control population for the TNF-α-308 polymorphism (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" alttext="$p = 0.0135$" id="E3"><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.0135</mml:mn></mml:math>). There was also variation in the frequency of IL-6-174 and TNF-α-308 genotypes in the ulcerative colitis group compared with the Crohn's disease group (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" alttext="$p = 0.01$" id="E4"><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.01</mml:mn></mml:math>). We concluded that polymorphisms in inflammatory genes are associated with variations in IBD phenotype and disease susceptibility. Whether the polymorphisms are directly involved in regulating cytokine production, and consequently pathophysiology of IBD, or serve merely as markers in linkage disequilibrium with susceptibility genes remains unclear.</jats:p>

Journal

Citations (2)*help

See more

Details 詳細情報について

Report a problem

Back to top